Measles seroprevalence among individuals serologically tested in Ontario, Canada
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Institute for Clinical Evaluative Sciences
- Institut canadien d'information sur la santé
- Ontario Ministry of Health and Long-Term Care
- Industrial Research and Consultancy Centre
- Canadian Institutes of Health Research
- Canadian Immunization Research Network
This publication has 27 references indexed in Scilit:
- The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccinationJournal of Infection and Public Health, 2023
- Increasing seroprevalence but waning herd immunity against measles after elimination: Longitudinal seroepidemiology of measles in Osaka Prefecture, Japan, 2003–2020Vaccine, 2022
- Population immunity to measles in Canada using Canadian Health Measures survey data – A Canadian Immunization Research Network (CIRN) studyVaccine, 2022
- Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort studyVaccine, 2022
- The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness – A systematic reviewVaccine, 2020
- Declining measles antibodies in the era of elimination: Australia’s experienceVaccine, 2018
- The basic reproduction number (R0) of measles: a systematic reviewThe Lancet Infectious Diseases, 2017
- An increasing, potentially measles-susceptible population over time after vaccination in KoreaVaccine, 2017
- Understanding Herd ImmunityTrends in Immunology, 2015
- Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverageVaccine, 1999